Pay in 4 interest-free payments of $5.07 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
4AllFamily Blog
2022;71: Altimmune Announces Positive Topline Results from MOMENTUM 48-Week Phase 2 Obesity Trial of Pemvidutide Altimmune
Contact Person: Sherry James, Corporate Sales Specialist U.S.A
It is not FDA-approved as a compounded combination product
Some patients may attempt supervised discontinuation after achieving significant metabolic improvements and implementing sustainable lifestyle changes
Despite their proven efficacy, affordability issues limit adoption among middle- and low-income populations
US$ 20.98
US$ 27.70
US$ 27.44
US$ 20.67
